Page 2479 - Hematology_ Basic Principles and Practice ( PDFDrive )

2214.e2 Part XII Hemostasis and Thrombosis

56. Belien Y: Safe epidural analgesia in thirty parturients with platelet 81. Reuvekamp A, Velsing-Aarts FV, Poulina IE, et al: Selective deficit
counts between 69,000 and 98,000 mm. Anesth Analg 85:385, 1997. of angiogenic growth factors characterises pregnancies complicated by
57. McCrae KR: Thrombocytopenia in pregnancy: differential diagnosis, pre-eclampsia. Br J Obstet Gynaecol 106:1019, 1999.
pathogenesis, and management. Blood Rev 17:7, 2003. 82. Zhou Y, McMaster M, Woo K, et al: Vascular endothelial growth factor
58. Lescale KB, Eddleman KA, Cines DB, et al: Antiplatelet antibody ligands and receptors that regulate human cytotrophoblast survival
testing in thrombocytopenic pregnant women. Am J Obstet Gynecol are dysregulated in severe preeclampsia and hemolysis, elevated liver
174:1014, 1996. enzymes, and low platelets syndrome. Am J Pathol 160:1405, 2002.
59. Boehlen F, Hohlfeld P, Extermann P, et al: Maternal antiplatelet 83. Graham CH, McCrae KR: Expression of gelatinase and plasminogen
antibodies in predicting the risk of neonatal thrombocytopenia. Obstet activator activity by trophoblast cells isolated from the placentae of
Gynecol 93:169, 1999. normal and preeclamptic women. Am J Obstet Gynecol 175:555,
60. Cohen D, Balgin T: Assessment and management of immune throm- 1996.
bocytopenia in pregnancy and neonates. Arch Dis Child Fetal Neonatal 84. Lam C, Lim K, Karumanchi SA: Circulating angiogenic factors in the
Ed 72:F71, 1995. pathogenesis and prediction of preeclampsia. Hypertension 46:1077,
61. George JN, Woolf SH, Raskob GE, et al: Idiopathic thrombocytopenic 2005.
purpura: a practice guideline developed by explicit methods for the 85. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol
American Society of Hematology. Blood 88:3, 1996. 2:656, 2002.
62. Clines DB, McMillan R: Management of adult idiopathic thrombocy- 86. Nova A, Sibai BM, Barton JR, et al: Maternal plasma level of endothelin
topenia purpura. Annu Rev Med 56:425, 2005. is increased in preeclampsia. Am J Obstet Gynecol 165:724, 1991.
63. Temprano R: Antirheumatic drugs in pregnancy and lactation. Semin 87. Halim A, Kanayama N, Maehara K, et al: HELLP syndrome-like bio-
Arthritis Rheum 35:112, 2005. chemical parameters obtained with endothelin-1 injections to rabbits.
64. Duck SC, Katayama KP: Danazol may cause female pseudohermaph- Gynecol Obstet Invest 35:193, 1993.
roditism. Fertil Steril 35:230, 1981. 88. Burrows RF, Hunter DJ, Andrew M, et al: A prospective study inves-
65. Stamilio DM, Macones GA: Selection of delivery methods in preg- tigating the mechanism of thrombocytopenia in preeclampsia. Obstet
nancies complicated by autoimmune thrombocytopenia: a decision Gynecol 70:334, 1987.
analysis. Obstet Gynecol 94:41, 1999. 89. Leduc L, Wheeler JM, Kirshon B, et al: Coagulation profile in severe
66. Sullivan CA, Martin JN: Management of the obstetric patient with preeclampsia. Obstet Gynecol 79:14, 1992.
thrombocytopenia. Clin Obstet Gynecol 38:521, 1995. 90. McCrae KR, Samuels P, Schreiber AD: Pregnancy-associated thrombo-
67. Samuels P, Bussel JB, Braitman LE, et al: Estimation of the risk cytopenia: pathogenesis and management. Blood 80:2697, 1992.
of thrombocytopenia in the offspring of pregnant women with pre- 91. Sibai BM, Ramadan MK, Usta I, et al: Maternal morbidity and mortal-
sumed immune thrombocytopenic purpura. N Engl J Med 323:229, ity in 442 pregnancies with hemolysis, elevated lived enzymes, and low
1990. platelets (HELLP syndrome). Am J Obstet Gynecol 169:1000, 1993.
68. Bessho T, Ida A, Minagawa K, et al: Effects of maternally administered 92. Miles JF, Jr, Martin JN, Jr, Blake PG, et al: Postpartum eclampsia: a
immunoglobulin on platelet counts of neonates born to mothers with recurring perinatal dilemma. Obstet Gynecol 76:328, 1990.
autoimmune thrombocytopenia: re-evaluation. Clin Exp Obstet Gynecol 93. Yamanaka Y, Takeuchi K, Konda E, et al: Transient postpartum diabetes
70:334, 1987. insipidus in twin pregnancy associated with HELLP syndrome. J Perinat
69. Karpatkin M, Porges RF, Karpatkin S: Platelet counts in infants of Med 30:273, 2002.
women with autoimmune thrombocytopenia: effect of steroid admin- 94. Audibert F, Friedman SA, Frangieh AY, et al: Clinical utility of strict
istration to the mother. N Engl J Med 305:936, 1981. diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes,
70. Payne SD, Resnik R, Moore TR, et al: Maternal characteristics and and low platelets) syndrome. Am J Obstet Gynecol 175:460, 1996.
risk of severe neonatal thrombocytopenia and intracranial hemorrhage 95. Geary M: The HELLP syndrome. Br J Obstet Gynaecol 104:887,
in pregnancies complicated by autoimmune thrombocytopenia. Am J 1997.
Obstet Gynecol 177:149, 1997. 96. Kleckner HB, Giles HR, Corrigan JJ: The association of maternal
71. Provan D, Newland A, Bolton-Maggs P: Guidelines for the investiga- and neonatal thrombocytopenia in high-risk pregnancies. Am J Obstet
tion and management of idiopathic thrombocytopenic purpura in Gynecol 128:235, 1977.
adults, children and in pregnancy. Br J Haematol 120:574, 2003. 97. Pritchard JA, Cunningham FG, Pritchard SA, et al: How often does
72. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 365:785, maternal preeclampsia-eclampsia incite thrombocytopenia in the fetus.
2005. Obstet Gynecol 69:292, 1987.
73. Valera M: Physiologic changes of platelets during pregnancy. Platelets 98. Burrows RF, Andrew M: Neonatal thrombocytopenia in the hyperten-
21:587, 2010. sive disorders of pregnancy. Obstet Gynecol 76:234, 1990.
74. Norwitz ER, Hsu CD, Repke JT: Acute complications of preeclampsia. 99. Sibai BM, Ramadan MK, Chari RS, et al: Pregnancies complicated
Clin Obstet Gynecol 45:308, 2002. by HELLP syndrome (hemolysis, elevated liver enzymes, and low
75. Mello G, Parretti E, Marozio L, et al: Thrombophilia is significantly platelets): subsequent pregnancy outcome and long-term prognosis.
associated with severe preeclampsia: results of a large-scale, case- Am J Obstet Gynecol 172:125, 1995.
controlled study. Hypertension 46:1270, 2005. 100. Sullivan CA, Magann EF, Perry KG, et al: The recurrence of the syn-
76. Sibai BM, Taslimi MM, El-Nazer A, et al: Maternal-perinatal outcome drome of hemolysis, elevated liver enzymes, and low platelets (HELLP)
associated with the syndrome of hemolysis, elevated liver enzymes, and in subsequent gestations. Am J Obstet Gynecol 171:940, 1994.
low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 101. Lain KY, Roberts JM: Contemporary concepts of the pathogenesis and
155:501, 1986. management of preeclampsia. JAMA 287:3183, 2002.
77. Martin JN, Jr, Blake PG, Lowry SL, et al: Pregnancy complicated by 102. Belfort MA, Anthony J, Saade GR, et al: A comparison of magnesium
preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver sulfate and nimodipine for the prevention of eclampsia. N Engl J Med
enzymes, and low platelet count: how rapid is postpartum recovery? 348:304, 2003.
Obstet Gynecol 76:737, 1990. 103. Amorim MMR, Santas LC, Faundes A: Corticosteroid therapy for
78. Torry DS, Wang HS, Wang TH, et al: Preeclampsia is associated with prevention of respiratory distress syndrome in severe preeclampsia. Am
reduced serum levels of placenta growth factor. Am J Obstet Gynecol J Obstet Gynecol 180:1283, 1999.
179:1539, 1998. 104. ACOG Committee on Obstetric Practice: Diagnosis and management
79. Sibai BM: The HELLP syndrome (hemolysis, elevated liver enzymes, of preeclampsia and eclampsia. Int J Gynaecol Obstet 77:67, 2002.
and low platelets): much ado about nothing? Am J Obstet Gynecol 105. Chames MC, Livingston JC, Ivester TS, et al: Late postpartum eclamp-
162:311, 1990. sia: a preventable disease? Am J Obstet Gynecol 186:1174, 2002.
80. Redman CW, Sargent IL: Latest advances in understanding preeclamp- 106. Varol F, Aydin T, Gucer F: HELLP syndrome and postpartum
sia. Science 308:1592, 2005. corticosteroids. Int J Gynaecol Obstet 73:157, 2001.